You just read:

Eloxx Pharmaceuticals Announces Orphan Drug Designation in the U.S. and Europe for ELX-02 in Mucopolysacchardisis Type 1 (MPS 1)

News provided by

Eloxx Pharmaceuticals

Nov 07, 2016, 09:00 ET